Latest News and Press Releases

2025 Letter to Shareholders

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug...

Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...

Tonner Drones erhält Patent für Inhibitor in den USA Schiltigheim, 23. April 2025, 18:00 Uhr, Tonner Drones gibt erfreut bekannt, dass sein Patent für den Inhibitor in den USA erteilt wurde. Tonner...

Tonner Drones Obtains Patent For Inhibitor In The United States Schiltigheim, April 23th 2025 18:00, Tonner Drones is pleased to announce that its patent for the Inhibitor is granted in the USA. ...

Tonner Drones obtient un brevet pour un inhibiteur aux États-Unis Schiltigheim, le 23 avril 2025 18h00, Tonner Drones a le plaisir d'annoncer que son brevet pour l'Inhibiteur est accordé aux USA. ...

Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...

BC3 Technologies has received a U.S. patent for its SEAL Hemostatic Wound Spray to stop blood loss fast.

COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h ...